CN1065269A - 哒嗪酮乙酸衍生物 - Google Patents
哒嗪酮乙酸衍生物 Download PDFInfo
- Publication number
- CN1065269A CN1065269A CN92102224A CN92102224A CN1065269A CN 1065269 A CN1065269 A CN 1065269A CN 92102224 A CN92102224 A CN 92102224A CN 92102224 A CN92102224 A CN 92102224A CN 1065269 A CN1065269 A CN 1065269A
- Authority
- CN
- China
- Prior art keywords
- base
- methyl
- formula
- oxo
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/30—Phthalazines
- C07D237/32—Phthalazines with oxygen atoms directly attached to carbon atoms of the nitrogen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67691991A | 1991-03-28 | 1991-03-28 | |
| US676,919 | 1991-03-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1065269A true CN1065269A (zh) | 1992-10-14 |
Family
ID=24716565
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN92102224A Pending CN1065269A (zh) | 1991-03-28 | 1992-03-27 | 哒嗪酮乙酸衍生物 |
Country Status (19)
| Country | Link |
|---|---|
| EP (1) | EP0582643A1 (2) |
| JP (1) | JPH06500793A (2) |
| CN (1) | CN1065269A (2) |
| AU (1) | AU658887B2 (2) |
| BR (1) | BR9205810A (2) |
| CA (1) | CA2107104A1 (2) |
| CZ (1) | CZ387092A3 (2) |
| DE (1) | DE9290035U1 (2) |
| FI (1) | FI934222A0 (2) |
| HU (1) | HUT67836A (2) |
| IE (1) | IE920979A1 (2) |
| IL (1) | IL101325A0 (2) |
| MX (1) | MX9201414A (2) |
| NZ (1) | NZ242152A (2) |
| PT (1) | PT100301A (2) |
| TW (1) | TW207998B (2) |
| WO (1) | WO1992017446A2 (2) |
| YU (1) | YU30392A (2) |
| ZA (1) | ZA922238B (2) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1236720B1 (en) * | 2001-02-28 | 2005-06-15 | Pfizer Products Inc. | Sulfonyl pyridazinone compounds useful as aldose reductase inhibitors |
| SE0100873D0 (sv) * | 2001-03-13 | 2001-03-13 | Astrazeneca Ab | Method of treatment |
| CA2442476A1 (en) | 2001-03-30 | 2002-10-10 | Pfizer Products Inc. | Pyridazinone aldose reductase inhibitors |
| AU761191B2 (en) * | 2001-05-24 | 2003-05-29 | Pfizer Products Inc. | Therapies for tissue damage resulting from ischemia |
| US7572910B2 (en) | 2003-02-20 | 2009-08-11 | Pfizer, Inc. | Pyridazinone aldose reductase inhibitors |
| CN111617072B (zh) * | 2019-02-27 | 2023-06-20 | 苏州凯祥生物科技有限公司 | 一种高尿酸血症药物组合物及用于治疗高尿酸血症的药物 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0676391B2 (ja) * | 1987-06-09 | 1994-09-28 | フアイザー・インコーポレイテツド | ベンゾチアゾール等の複素環側鎖を有するオキソフタラジニル酢酸類の製造方法 |
| FR2647676A1 (fr) * | 1989-06-05 | 1990-12-07 | Union Pharma Scient Appl | Nouveaux derives de pyridazinone, leurs procedes de preparation, medicaments les contenant, utiles notamment comme inhibiteurs de l'aldose reductase |
-
1992
- 1992-03-09 WO PCT/US1992/001603 patent/WO1992017446A2/en not_active Ceased
- 1992-03-09 EP EP92910955A patent/EP0582643A1/en not_active Withdrawn
- 1992-03-09 HU HU9302728A patent/HUT67836A/hu unknown
- 1992-03-09 JP JP4509938A patent/JPH06500793A/ja active Pending
- 1992-03-09 FI FI934222A patent/FI934222A0/fi not_active Application Discontinuation
- 1992-03-09 CZ CS923870A patent/CZ387092A3/cs unknown
- 1992-03-09 CA CA002107104A patent/CA2107104A1/en not_active Abandoned
- 1992-03-09 BR BR9205810A patent/BR9205810A/pt not_active Application Discontinuation
- 1992-03-09 DE DE9290035U patent/DE9290035U1/de not_active Expired - Lifetime
- 1992-03-09 AU AU17796/92A patent/AU658887B2/en not_active Ceased
- 1992-03-13 TW TW081101914A patent/TW207998B/zh active
- 1992-03-22 IL IL101325A patent/IL101325A0/xx unknown
- 1992-03-26 PT PT100301A patent/PT100301A/pt not_active Application Discontinuation
- 1992-03-26 YU YU30392A patent/YU30392A/sh unknown
- 1992-03-27 CN CN92102224A patent/CN1065269A/zh active Pending
- 1992-03-27 NZ NZ24215292A patent/NZ242152A/en unknown
- 1992-03-27 MX MX9201414A patent/MX9201414A/es unknown
- 1992-03-27 IE IE097992A patent/IE920979A1/en not_active Application Discontinuation
- 1992-03-27 ZA ZA922238A patent/ZA922238B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| YU30392A (sh) | 1994-11-15 |
| JPH06500793A (ja) | 1994-01-27 |
| IL101325A0 (en) | 1992-11-15 |
| FI934222A7 (fi) | 1993-09-27 |
| AU1779692A (en) | 1992-11-02 |
| PT100301A (pt) | 1993-06-30 |
| HU9302728D0 (en) | 1993-12-28 |
| BR9205810A (pt) | 1994-06-28 |
| CA2107104A1 (en) | 1992-09-29 |
| AU658887B2 (en) | 1995-05-04 |
| EP0582643A1 (en) | 1994-02-16 |
| DE9290035U1 (de) | 1993-11-18 |
| HUT67836A (en) | 1995-05-29 |
| IE920979A1 (en) | 1992-10-07 |
| MX9201414A (es) | 1992-10-01 |
| FI934222L (fi) | 1993-09-27 |
| ZA922238B (en) | 1993-09-27 |
| FI934222A0 (fi) | 1993-09-27 |
| TW207998B (2) | 1993-06-21 |
| WO1992017446A3 (en) | 1992-11-26 |
| WO1992017446A2 (en) | 1992-10-15 |
| NZ242152A (en) | 1994-07-26 |
| CZ387092A3 (en) | 1994-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1290848C (zh) | 作为治疗或预防糖尿病的二肽基肽酶抑制剂的β－氨基四氢咪唑并(1,2－A)吡嗪和四氢三唑并(4,3－A)吡嗪 | |
| CN1041087C (zh) | 芳基乙酰胺及其制备方法和应用 | |
| CN1250549C (zh) | 吲哚衍生物及其作为5－ht2b和5－ht2c受体配体的应用 | |
| CN1034865C (zh) | 2-氨基嘧啶酮的制备方法 | |
| CN1070477C (zh) | 吲哚衍生物 | |
| CN1034176C (zh) | 用于预防和治疗糖尿病并发症的药物组合物的制备方法 | |
| CN1015057B (zh) | 哌嗪基-杂环化合物的制备方法 | |
| CN1040025A (zh) | 新的四氢苯并吲哚丙酸磺酰胺的制备 | |
| CN1835936A (zh) | 用于治疗阿尔茨海默氏病的大环β－分泌酶抑制剂 | |
| CN1006792B (zh) | 羟基、烷氧基和苯氧嘧啶类的制备方法 | |
| CN1610683A (zh) | 作为磷酸酶抑制剂的嘧啶并三嗪 | |
| CN1729173A (zh) | N－(吲哚乙基)环胺化合物 | |
| CN1049657A (zh) | 二取代(喹啉-2-基-甲氧基)苯乙酸衍生物 | |
| CN87104099A (zh) | 抗变态反应和消炎药剂 | |
| CN1074904A (zh) | 苯并呋喃基-和噻吩基甲硫基-链烷羧酸衍生物 | |
| CN1097006A (zh) | O-芳基吗啡喃的醚类化合物 | |
| CN1942437A (zh) | 作为环氧化酶－1－环氧化酶－2抑制剂的取代氮杂环丁烷化合物及其制备方法和作为药物的用途 | |
| CN86107695A (zh) | 不同的氮-取代的3-哌啶羧酸或氮-取代的3-吡啶羧酸及它们的衍生物 | |
| CN1065269A (zh) | 哒嗪酮乙酸衍生物 | |
| CN1015627B (zh) | 芳香基呱嗪基-亚烷基苯基-杂环化合物的制备方法 | |
| HK1045809A1 (en) | Utilization of polycyclic 2-amino-thiazole systems in the production of medicaments for prophylaxis or treatment of obesity | |
| CN1070190A (zh) | 杂环取代的喹啉甲氧基苯乙酰胺 | |
| CN1027066C (zh) | 吲哚衍生物的制备方法 | |
| CN1090629C (zh) | 新的杂环化合物 | |
| CN101048392A (zh) | 新用途 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| AD01 | Patent right deemed abandoned | ||
| C20 | Patent right or utility model deemed to be abandoned or is abandoned |